{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:49:28Z","timestamp":1791524968389,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008673","name":"Center for AIDS Research, University of California, San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lana.2026.101577","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:48:20Z","timestamp":1784299700000},"page":"101577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Methadone treatment and associated health and social outcomes after a national manufacturing closure in Mexico: a longitudinal observational cohort study in Tijuana"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2796-3520","authenticated-orcid":false,"given":"Jesse Lloyd","family":"Goldshear","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Harvey-Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudelia","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Abramovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha K.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffanie A.","family":"Strathdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Medina-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"B\u00f3rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lana.2026.101577_bib1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/QAI.0000000000000165","article-title":"HIV risk reduction with buprenorphine\u2013naloxone or methadone: findings from a randomized trial","volume":"66","author":"Woody","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.lana.2026.101577_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/add.14012","article-title":"Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a cochrane review and meta-analysis","volume":"113","author":"Platt","year":"2018","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.lana.2026.101577_bib3","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.lana.2026.101577_bib4","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.lana.2026.101577_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugpo.2009.10.004","article-title":"Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings","volume":"21","author":"Bruce","year":"2010","journal-title":"Int J Drug Policy"},{"issue":"5","key":"10.1016\/j.lana.2026.101577_bib6","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/add.15736","article-title":"Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia","volume":"117","author":"Chaillon","year":"2022","journal-title":"Addict Abingdon Engl"},{"issue":"3","key":"10.1016\/j.lana.2026.101577_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.psychres.2014.11.023","article-title":"The reductions in monetary cost and gains in productivity with methadone maintenance treatment: one year follow-up","volume":"225","author":"Hsiao","year":"2015","journal-title":"Psychiatry Res"},{"issue":"3\u20134","key":"10.1016\/j.lana.2026.101577_bib8","first-page":"66","article-title":"Physical effects of methadone maintenance treatment from the standpoint of clients","volume":"2","author":"Kheradmand","year":"2010","journal-title":"Addict Health"},{"issue":"1","key":"10.1016\/j.lana.2026.101577_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40359-014-0026-3","article-title":"Improving psychosocial health and employment outcomes for individuals receiving methadone treatment: a realist synthesis of what makes interventions work","volume":"2","author":"Jackson","year":"2014","journal-title":"BMC Psychol"},{"key":"10.1016\/j.lana.2026.101577_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108221","article-title":"Health-related quality of life and opioid use disorder pharmacotherapy: a secondary analysis of a clinical trial","volume":"215","author":"Jalali","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.lana.2026.101577_bib11","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1016\/S2214-109X(23)00058-X","article-title":"Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review","volume":"11","author":"Colledge-Frisby","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.lana.2026.101577_bib12","first-page":"100520","article-title":"Addressing opioid use disorder: mexico\u2019s step backwards","volume":"23","author":"Strathdee","year":"2023","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"10.1016\/j.lana.2026.101577_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12954-018-0234-x","article-title":"Cost of provision of opioid substitution therapy provision in Tijuana, Mexico","volume":"15","author":"Burgos","year":"2018","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.lana.2026.101577_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-022-12955-x","article-title":"Structural violence and the need for compassionate use of methadone in Mexico","volume":"22","author":"Romero-Mendoza","year":"2022","journal-title":"BMC Public Health"},{"issue":"8","key":"10.1016\/j.lana.2026.101577_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.arcmed.2019.12.013","article-title":"Opioid crisis along Mexico\u2019s Northern border: treatment needs Mexican opioid crisis","volume":"50","author":"Fleiz","year":"2019","journal-title":"Arch Med Res"},{"issue":"4","key":"10.1016\/j.lana.2026.101577_bib16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/add.14934","article-title":"Fentanyl is used in Mexico\u2019s northern border: current challenges for drug health policies","volume":"115","author":"Fleiz","year":"2020","journal-title":"Addict Abingdon Engl"},{"issue":"7","key":"10.1016\/j.lana.2026.101577_bib17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2105\/AJPH.2024.307650","article-title":"Spatial heterogeneity in fatal overdose rate trends in Mexican cities: 2005\u20132021","volume":"114","author":"Henson","year":"2024","journal-title":"Am J Public Health"},{"key":"10.1016\/j.lana.2026.101577_bib18","article-title":"Impact of an overdose reversal program in the context of a safe consumption site in Northern Mexico","volume":"2","author":"Goodman-Meza","year":"2022","journal-title":"Drug Alcohol Depend Rep"},{"issue":"1","key":"10.1016\/j.lana.2026.101577_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2105\/AJPH.2018.304767","article-title":"Where is the opioid use epidemic in Mexico? A cautionary tale for policymakers south of the US\u2013Mexico border","volume":"109","author":"Goodman-Meza","year":"2019","journal-title":"Am J Public Health"},{"key":"10.1016\/j.lana.2026.101577_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103678","article-title":"The introduction of fentanyl on the US\u2013Mexico border: an ethnographic account triangulated with drug checking data from Tijuana","volume":"104","author":"Friedman","year":"2022","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.lana.2026.101577_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109644","article-title":"Correlates of recent overdose among people who inject drugs in the San Diego\/Tijuana border region","volume":"240","author":"Bailey","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.lana.2026.101577_bib22","series-title":"La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (Cofepris)","year":"2023"},{"key":"10.1016\/j.lana.2026.101577_bib23","first-page":"101176","article-title":"A qualitative exploration of the downstream impact of a sustained disruption to the methadone supply in Mexico: effects on the mental, financial, and social health of patients with opioid use disorder in Tijuana","volume":"49","author":"B\u00f3rquez","year":"2025","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.lana.2026.101577_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1238188","article-title":"Qualitative exploration of the early experiences of opioid use disorder patients from private clinics after Russia\u2019s invasion of Ukraine in five major cities in Ukraine","volume":"11","author":"Mazhnaya","year":"2023","journal-title":"Front Public Health"},{"issue":"4","key":"10.1016\/j.lana.2026.101577_bib25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0022042618779541","article-title":"A crisis within a crisis: the extended closure of an opioid treatment program after Hurricane sandy","volume":"48","author":"Griffin","year":"2018","journal-title":"J Drug Issues"},{"issue":"2","key":"10.1016\/j.lana.2026.101577_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0749-3797(18)30622-6","article-title":"Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale)","volume":"10","author":"Andresen","year":"1994","journal-title":"Am J Prev Med"},{"issue":"10","key":"10.1016\/j.lana.2026.101577_bib27","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lana.2026.101577_bib28","series-title":"\u2018I'm back in withdrawal\u2019: methadone shortage is hitting opioid users hard in Mexico","author":"Bonello","year":"2023"},{"key":"10.1016\/j.lana.2026.101577_bib29","series-title":"Desabasto de metadona mata a los adictos a la hero\u00edna y al fentanilo","article-title":"Grupo milenio","author":"Rivera","year":"2023"},{"issue":"1","key":"10.1016\/j.lana.2026.101577_bib30","article-title":"Generalized estimating equations in longitudinal data analysis: a review and recent developments","volume":"2014","author":"Wang","year":"2014","journal-title":"Adv Stat"},{"key":"10.1016\/j.lana.2026.101577_bib31","article-title":"The impact of the 2014 military conflict in the east of Ukraine and the Autonomous Republic of the Crimea among patients receiving opioid agonist therapies","volume":"160","author":"Meteliuk","year":"2024","journal-title":"J Subst Use Addict Treat"},{"issue":"12","key":"10.1016\/j.lana.2026.101577_bib32","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3109\/10826080902962011","article-title":"Lessons learned from the deadly sisters: drug and alcohol treatment disruption, and consequences from hurricanes Katrina and Rita","volume":"44","author":"Carlisle Maxwell","year":"2009","journal-title":"Subst Use Misuse"},{"issue":"7","key":"10.1016\/j.lana.2026.101577_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.23708","article-title":"Changes in buprenorphine and methadone supplies in the US during the COVID-19 pandemic","volume":"5","author":"Chen","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lana.2026.101577_bib34","article-title":"Implementing a decentralized opioid overdose prevention strategy in Mexico, a pending public policy issue","volume":"23","author":"Bejarano Romero","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.lana.2026.101577_bib35","series-title":"Gu\u00eda t\u00e9cnica del programa de mantenimiento Y deshabituaci\u00f3n CON metadona (PMDM)","year":"2024"},{"issue":"1","key":"10.1016\/j.lana.2026.101577_bib36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/dar.12524","article-title":"Latent classes of polydrug and polyroute use and associations with human immunodeficiency virus risk behaviours and overdose among people who inject drugs in Tijuana, Baja California, Mexico","volume":"37","author":"Meacham","year":"2018","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"10.1016\/j.lana.2026.101577_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugalcdep.2013.05.014","article-title":"Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing","volume":"133","author":"Corson","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.lana.2026.101577_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.100292","article-title":"A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico\u2014A systematic review and meta-analysis (2008\u20132019)","volume":"20","author":"Sede\u00f1o-Monge","year":"2021","journal-title":"Ann Hepatol"},{"issue":"9740","key":"10.1016\/j.lana.2026.101577_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(10)60883-5","article-title":"Tackling HIV and drug addiction in Mexico","volume":"376","author":"Moreno","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.lana.2026.101577_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S2215-0366(22)00339-X","article-title":"Burden of disease due to amphetamines, cannabis, cocaine, and opioid use disorders in South America, 1990\u20132019: a systematic analysis of the Global burden of Disease Study 2019","volume":"10","author":"Castaldelli-Maia","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"10297","key":"10.1016\/j.lana.2026.101577_bib41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0140-6736(21)01656-1","article-title":"Lack of medicines in Mexico","volume":"398","author":"Agren","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.lana.2026.101577_bib42","first-page":"100557","article-title":"Opioid crisis: addiction, overprescription, and insufficient primary prevention","volume":"23","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.lana.2026.101577_bib43","series-title":"Opioid agonist maintenance treatment as an essential health service: implementation guidance on mitigating disruption of services for treatment of opioid dependence","year":"2025"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X26002073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X26002073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:56:02Z","timestamp":1791521762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X26002073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S2667193X26002073"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2026.101577","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methadone treatment and associated health and social outcomes after a national manufacturing closure in Mexico: a longitudinal observational cohort study in Tijuana","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2026.101577","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101577"}}